Scott Lippman, M.D.

Scott M. Lippman, M.D., is director of Moores Cancer Center at UC San Diego Health, professor of Medicine at UC San Diego School of Medicine, senior associate dean and associate vice chancellor for Cancer Research and Care and holds the Chugai Pharmaceutical Chair in Cancer. He is also an adjunct…...

Read more

Fei Shen, Ph.D.

Fei is an Investment Director in the Boehringer Ingelheim Corporate Venture Fund. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. Fei received her Ph.D. in Neuropharmacology from Loyola University Chicago Stritch School of Medicine and a B.Sc in Biochemistry from East China University…...

Read more

Lance Kawaguchi, Chairman

Mr. Lance Kawaguchi is an internationally recognized executive leader and board member, with over 25 years of global finance and banking experience, including living and working throughout North America, Europe, Asia Pacific, and the Middle East. Lance is the CEO of Cure Brain Cancer Foundation, a non-profit organization in Australia…...

Read more

Gary Gee Nung Wong

Partner, Hugill & Ip Solicitors...

Read more

Perchow Joseph Chang, M.B.A.

Perchow Joseph Chang is a China-based executive, currently a Managing Director with Prosperity7 Ventures, where he serves as the senior leader in China for Saudi Aramco’s $1 billion diversification fund, focusing on making venture and growth investments in disruptive and emerging technologies and industries that could provide a new source…...

Read more

Pamela D. Garzone, Ph.D.

Pamela D. Garzone is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the level of Chief Medical Officer. She has led teams successfully through the regulatory process, culminating in the clearance of multiple INDs in different therapeutic areas and approval of…...

Read more

Aleksandra Filipovic, M.D., Ph.D.

Aleksandra Filipovic MD, PhD, is head of oncology at PureTech, where she manages Oncology Asset Sourcing, review of oncology/ immuno oncology technologies and platforms from academia world-wide as well as biotech assets and pipelines amenable for commercialization and partnership. She is also responsible for pre-clinical and clinical development of therapeutics,…...

Read more

Dimitra Georganopoulou, Ph.D.

Dimitra currently serves on the Innovation Faculty of MIT linQ CATALYST. In this capaticy she mentors and guides innovators to accelerate and heighten the impact of their solutions on serious health and medical challenges. Dimitra was responsible for assessing and promoting inventions generated at Northwestern University as the Innovation and…...

Read more

Alfred Slanetz, Ph.D.

Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since its incorporation in 2012. Geneius, an immuno-oncology start-up, is researching ways to help cancer patients’ immune systems detect and attack…...

Read more

Will Liu, Ph.D.

Dr. Will Liu is a Partner of Eight Roads Ventures China, specializing in healthcare investment.  Dr. Liu has twenty years of experience in the pharmaceutical and biotech industries, both in R&D and in business development. Prior to joining Eight Roads, he held several positions of business development in multinational pharmaceutical…...

Read more